Literature DB >> 16282739

[Complete disappearance of metastatic lung tumors and mediastinal lymphnode in a case of hepatocellular carcinoma treated by low-dose 5-fluorouracil/cisplatin therapy].

Yoji Anami1, Shin Oguma, Yoshio Matsuda, Takashi Yamaki, Yoshiro Sazawa, Hirofumi Komiya, Junko Izai, Tomoyuki Ota.   

Abstract

We report a case of complete disappearance of multiple lung metastases and mediastinal lymphnode metastasis by intravenous administration of 5-fluorouracil/cisplatin (FP) after operation for primary hepatocellular carcinoma (HCC). A 54-year-old male was diagnosed with HCC associated with alcoholic liver cirrhosis. He also had a single lung metastasis at the time of diagnosis. After hepatic resection for HCC, the metastatic tumor progressed and became multiple lesions with mediastinal lymphnode involvements. Low-dose FP therapy was performed. Then, 250 mg/m(2)/day of 5-fluorouracil was given intravenously for 5 days weekly by continuous infusion and 10 mg/m(2)/day of cisplatin by intravenous infusion. Both lung metastases and mediastinal lymphnode metastasis were decreasing after six cycles of this therapy. Because of alcoholism and liver damage, chemotherapy could not be continued. But all metastatic lesions were completely disappeared ten months after this therapy. Bone marrow suppression (grade 4) was observed during the chemotherapy but resolved by interruption of treatment. Low-dose FP therapy may well be useful for patients suffering from advanced HCC with distant metastasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282739

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  A case of hepatocellular carcinoma with pulmonary metastases treated successfully with a combination of repeated hepatic arterial infusion epirubicin and Cisplatin chemotherapy and systemic low-dose infusion of 5-Fluorouracil.

Authors:  Yun-Jung Oh; Young-Min Park; Bo-Hyun Kim; Mi-Jin Kim; Jun-Hyung Cho; Chi-Woon Cha; Sang-Jong Park; Jae-Woo Yeon
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

2.  Substernal Mass: A Rare Presentation of Hepatocellular Carcinoma.

Authors:  Kevin Yuqi Wang; Mohammad Ghasemi Rad; Camelia Arsene; Doina David
Journal:  Oman Med J       Date:  2019-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.